SHENZHEN, China Aug. 26 /Xinhua-PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China, today released select historical financial figures converted from Chinese Renminbi to U.S. Dollars.
As announced in May, 2008, Mindray changed its reporting currency to the U.S. Dollar (USD) from Chinese Renminbi effective April 1, 2008. Accordingly, Mindray has issued these historical financial results in USD in order to allow same currency comparisons to future financial results, which will be released in USD. This conversion does not reflect any change in the underlying historical results and reflects only exchange rate recalculation into USD based on the accounting guidance for retranslation into a new reporting currency.
Mindray’s USD financial figures are available in the Securities and Exchange Commission section of Mindray’s website at http://ir.mindray.com , or as filed with the Securities and Exchange Commission at http://www.sec.gov .
About Mindray
Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring & life support products, in-vitro diagnostic products and medical imaging systems. Mindray is globally headquartered in Shenzhen, China, with U.S. headquarters in Mahwah, New Jersey. Mindray also has another 12 international sales and service offices in Amsterdam, Frankfurt, Istanbul, London, Mexico City, Moscow, Mumbai, Paris, Sao Paolo, Seattle, Toronto and Vancouver.
